Biosimilar

Do you have an idea for The New Times to cover? Submit it here!
Search Results for "Biosimilar" (6 articles)
A patient undergoes eye screening at Rwanda Charity Eye Hospital, located in Bishenyi, Runda sector, Kamonyi district. Photo by Willy Mucyo

What your eyes reveal about your health

Tuesday, November 18, 2025
Dr. Menghis Bairu (L) is President & CEO of biotech company Bio Usawa, whereas Prof. Wanjiku Mathenge (R) is a renowned ophthalmologist in Africa.

Rwanda’s approval of first eye care biosimilar offers hope for millions

Thursday, October 23, 2025
Rwanda has approved BioUcenta™, a lower-cost drug similar to Lucentis® (ranibizumab), to treat diabetic macular edema
Health

Rwanda FDA approves Africa’s first affordable eye drug

Tuesday, October 21, 2025
Dr. Menghis Bairu captures a quiet moment overlooking Lake Kivu during a weekend stay at Cleo Hotel in Western Rwanda

From scenic views to unexpected talent: My weekend at Lake Kivu

Monday, July 28, 2025
Menghis Bairu, the Chief Executive Officer of Bio Usawa and Francis Gatare, Rwanda Development Board's Chief Executive Officer in February 2024. Courtesy
Health

Rwanda, Bio Usawa ink deal to manufacture affordable eye treatments in Africa

Friday, November 22, 2024
The New Times

Why do Americans pay more for drugs?

Wednesday, April 24, 2019